Giangennaro Coppola Selected Research

rufinamide

11/2020	Cognitive, adaptive, and behavioral effects of adjunctive rufinamide in Lennox-Gastaut syndrome: A prospective observational clinical study.
1/2017	New developments in the management of partial-onset epilepsy: role of brivaracetam.
1/2015	Successful Treatment of Refractory Seizures With Rufinamide in Children With Schizencephaly: Report of 3 Cases.
11/2014	Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.
9/2014	Efficacy and safety of rufinamide in children under four years of age with drug-resistant epilepsies.
3/2014	Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders.
1/2013	Rufinamide for refractory focal seizures: an open-label, multicenter European study.
3/2011	Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases.
1/2011	Update on rufinamide in childhood epilepsy.
11/2010	Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giangennaro Coppola Research Topics

Disease

46	Seizures (Absence Seizure) 10/2021 - 03/2002
36	Epilepsy (Aura) 07/2022 - 01/2004
9	Drug Resistant Epilepsy 08/2015 - 02/2002
8	Brain Diseases (Brain Disorder) 01/2018 - 05/2010
6	Lennox Gastaut Syndrome 11/2020 - 09/2002
5	Epileptic Syndromes 11/2020 - 01/2011
4	Migraine Disorders (Migraine) 06/2020 - 09/2012
4	Partial Epilepsies (Epilepsy, Partial) 01/2020 - 02/2009
4	Absence Epilepsy (Childhood Absence Epilepsy) 10/2013 - 01/2004
4	Temporal Lobe Epilepsy 07/2013 - 05/2008
3	Generalized Epilepsy 01/2020 - 02/2002
3	Obesity 05/2018 - 02/2010
3	Weight Gain 05/2018 - 02/2010
3	Body Weight (Weight, Body) 02/2015 - 02/2010
3	Myoclonic Epilepsies (Myoclonic Encephalopathy) 04/2011 - 03/2002
3	Intellectual Disability (Idiocy) 09/2009 - 09/2004
2	Mental Disorders (Mental Disorder) 01/2020 - 05/2016
2	Insulin Resistance 05/2018 - 02/2015
2	Idiopathic Generalized Epilepsy 06/2017 - 10/2013
2	Infantile Spasms (West Syndrome) 12/2013 - 09/2002
2	Glioma (Gliomas) 07/2013 - 05/2008
2	Spasm (Spasms) 01/2011 - 08/2003
2	Syncope (Fainting) 11/2010 - 09/2002
2	Tuberous Sclerosis (Bourneville's Disease) 05/2006 - 01/2006
1	Autistic Disorder (Autism) 01/2021
1	Migraine with Aura (Familial Hemiplegic Migraine) 06/2020
1	Mood Disorders (Mood Disorder) 01/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2019
1	Kleine-Levin Syndrome (Syndrome, Kleine-Levin) 01/2019
1	Neutropenia 01/2019
1	Tonic-Clonic Epilepsy (Epilepsy, Tonic Clonic) 06/2017
1	Headache (Headaches) 06/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2017
1	Autism Spectrum Disorder 01/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Alternating hemiplegia of childhood 01/2017
1	Osteoporosis 01/2016
1	Rett Syndrome (Rett's Disorder) 01/2016
1	Weight Loss (Weight Reduction) 02/2015

Drug/Important Bio-Agent (IBA)

30	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 01/2004
25	Pharmaceutical PreparationsIBA 11/2020 - 03/2002
11	Valproic Acid (Depakote)FDA LinkGeneric 05/2021 - 01/2004
10	Levetiracetam (Keppra)FDA LinkGeneric 05/2021 - 01/2004
10	rufinamide FDA Link 11/2020 - 11/2010
6	Topiramate (Topamax)FDA LinkGeneric 02/2015 - 03/2002
5	Carbamazepine (Tegretol)FDA LinkGeneric 05/2021 - 01/2004
4	perampanelIBA 10/2021 - 01/2017
3	Hormones (Hormone)IBA 07/2022 - 05/2011
3	Oxcarbazepine (Trileptal)FDA LinkGeneric 05/2021 - 06/2007
3	Antipsychotic Agents (Antipsychotics)IBA 05/2018 - 05/2016
3	LeptinIBA 05/2018 - 09/2012
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2008
3	Lamotrigine (Lamictal)FDA LinkGeneric 09/2004 - 09/2002
2	Glucose (Dextrose)FDA LinkGeneric 05/2018 - 02/2010
2	GhrelinIBA 05/2018 - 02/2015
2	Peptides (Polypeptides)IBA 05/2018 - 09/2012
2	Immunoglobulin E (IgE)IBA 06/2017 - 10/2013
2	Lacosamide FDA Link 01/2017 - 04/2013
2	CalciumIBA 01/2016 - 01/2010
2	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2013 - 09/2002
2	Leucine (L-Leucine)FDA Link 07/2013 - 05/2008
2	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2011 - 12/2009
2	Zonisamide (Zonegran)FDA LinkGeneric 02/2009 - 01/2004
1	AMPA Receptors (AMPA Receptor)IBA 09/2021
1	Ethosuximide (Zarontin)FDA LinkGeneric 05/2021
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2020
1	Excitatory Amino Acid AntagonistsIBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	AcidsIBA 01/2020
1	LithiumIBA 01/2019
1	Clozapine (Clozaril)FDA LinkGeneric 01/2019
1	CannabidiolIBA 12/2018
1	cannabidivarinIBA 12/2018
1	Complement Factor D (Factor D)IBA 05/2018
1	C-PeptideIBA 05/2018
1	Nicotinamide PhosphoribosyltransferaseIBA 05/2018
1	bioplexIBA 05/2018
1	Dietary Fats (Dietary Fat)IBA 01/2018
1	CytokinesIBA 11/2017
1	ChemokinesIBA 11/2017
1	LigandsIBA 01/2017
1	eslicarbazepineIBA 01/2017
1	brivaracetamIBA 01/2017
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	eslicarbazepine acetateIBA 01/2016
1	Vitamin D FDA LinkGeneric 01/2016
1	zaleplon (Sonata)FDA LinkGeneric 09/2015
1	LDL CholesterolIBA 02/2015
1	Triglycerides (Triacylglycerol)IBA 02/2015
1	CholesterolIBA 02/2015
1	HDL CholesterolIBA 02/2015

Therapy/Procedure

28	Therapeutics 07/2022 - 09/2002
12	Ketogenic Diet 07/2022 - 02/2002
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2011
2	Music Therapy 01/2018 - 09/2015
2	Vagus Nerve Stimulation 05/2012 - 01/2004
1	Rehabilitation 01/2021
1	Drug Tapering 01/2020
1	First Aid (Aids, First) 10/2015